Metraipolis › archive › dc_67c565e1f69b

Assessing the impact of a second IVIG dose on patients with Guillain-Barré Syndrome: A synthesis without meta-analysis (SWiM) — Europe PMC PMID:41030879

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41030879
DOI
10.5339/qmj.2025.88
License (as archived)
solo-consultazione
Archived
2026-11-09T18:17:22.198Z
SHA-256 of the archived text
2f059bd171cb22c762580b8c62c7e185ae0302997678cb0d93852c18324f8b63
Stable URL of this page
https://metraipolis.com/documento/dc_67c565e1f69b

How to cite

Assessing the impact of a second IVIG dose on patients with Guillain-Barré Syndrome: A synthesis without meta-analysis (SWiM) — Europe PMC PMID:41030879 — Europe PMC (en), https://europepmc.org/article/MED/41030879 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67c565e1f69b (Metraipolis archive dc_67c565e1f69b, sha256 2f059bd171cb22c762580b8c62c7e185ae0302997678cb0d93852c18324f8b63)
BibTeX
@misc{dc67c565e1f69b,
  title = {Assessing the impact of a second IVIG dose on patients with Guillain-Barré Syndrome: A synthesis without meta-analysis (SWiM) — Europe PMC PMID:41030879},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41030879},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67c565e1f69b; sha256 2f059bd171cb22c762580b8c62c7e185ae0302997678cb0d93852c18324f8b63},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41030879. Agents can read the archived copy with the MCP tool read_document.